Form D · Other Investment Fund

RPS BioPharma Holdings, LP

George Town, E9 · CIK 0001702585

Offering snapshot reported Apr 10, 2017 · SEC filing

Reported sold: $150M
Investors reported: 21
Minimum accepted: $100K
First sale: Mar 27, 2017

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 10, 2017	Initial	$149,581,598	No comparison	21	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-284413

Source: Form D, filed Apr 10, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

RPS BIOPHARMA HOLDINGS, LP

Investment adviser: RP MANAGEMENT, LLC

Gross asset value: $32.8M
Beneficial owners: 52
ADV minimum commitment: $0

Reported in Form ADV on Mar 30, 2021. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES WINDSOR, Connecticut, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor ERNST & YOUNG LLP DUBLIN, Ireland

Custodian BANK OF AMERICA NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

ERNST & YOUNG LLP
PCAOB 1411

Filing source

Form ADV 1513828 · Mar 30, 2021 · Schedule D 7.B.(1), fund 805-5405440160

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Pablo Legorreta	Director
N/A Pharma Management (Cayman) Ltd.	Promoter
Rory Riggs	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

27 Hospital Road
George Town, E9, KY1-9008